The aim of this observational multicenter cohort study is to gain a deeper understanding regarding the effects of treatment adaption based on information from outcome prediction models, risk stratification, as well as treatment monitoring, detection, prevention, and management of complications on course and outcome of adult patients with status epilepticus (SE).
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Demographics
Timeframe: between 01.01.2005 and 31.12.2023
Data from acute prehospital management by the emergency medical services (EMS)
Timeframe: between 01.01.2005 and 31.12.2023
Duration of ICU (intensive care unit) and hospital stay, and destination at discharge
Timeframe: between 01.01.2005 and 31.12.2023
Date(s) of seizure(s) captured by electroencephalographic (EEG) data
Timeframe: between 01.01.2005 and 31.12.2023
Seizure history and etiology
Timeframe: between 01.01.2005 and 31.12.2023
Number and Duration of SE episodes
Timeframe: between 01.01.2005 and 31.12.2023
Types of SE
Timeframe: between 01.01.2005 and 31.12.2023
Additional features of the seizure
Timeframe: between 01.01.2005 and 31.12.2023
ICU Scoring Systems
Timeframe: between 01.01.2005 and 31.12.2023
Clinical neurologic monitoring scores
Timeframe: between 01.01.2005 and 31.12.2023
Laboratory parameters
Timeframe: between 01.01.2005 and 31.12.2023
Outcome measure
Timeframe: between 01.01.2005 and 31.12.2023
Therapeutic features
Timeframe: between 01.01.2005 and 31.12.2023
Monitoring of vital signs
Timeframe: between 01.01.2005 and 31.12.2023